Online Education

18CE071 - Understanding Hemophilia

The purpose of this activity is to introduce the learner to the basic aspects of hemophilia, including the deficit that interferes with formation of the stable fibrin clot, different types and severity levels of hemophilia, the inheritance pattern and special considerations for persons who are carriers of the gene, and the basic laboratory tests used to diagnose hemophilia.

• Define hemostasis and its three major processes
• Explain the deficit in hemophilia that interferes with formation of a stable fibrin clot
• Construct a diagram explaining sex-linked genetics of hemophilia
• Distinguish predicted bleeding patterns and clinical presentation based upon a classification of hemophilia as severe, moderate or mild
• Determine target factor levels for hemarthroses and muscle bleeds, major bleeds, and surgical management of hemophilia
• Differentiate hemophilia treatment methods including the four types of prophylaxis
• Discuss nursing considerations to be made when administering clotting factor products to patients
• Relate introductory information regarding factor XI deficiency

Nurses and other clinical staff within the federally recognized U.S. hemophilia treatment center (HTC) network who wish to expand their understanding of basic concepts of hemophilia

This module explores the three major steps in normal hemostasis, with particular emphasis on the key components of normal fibrin clot formation; and illustrates the coagulation cascade in an animated model. The module examines many basic aspects of hemophilia, including the deficit that interferes with formation of the stable fibrin clot, the different types and severity levels of hemophilia, the inheritance pattern and special considerations for persons who are carriers of the gene, and the basic laboratory tests used to diagnose hemophilia. Finally, the module describes in depth the treatment and management recommendations for different complications associated with each clinical severity level of hemophilia.

• Jennifer Maahs, MSN, PNP, RN-BC
• Amy Shapiro, MD

May 15, 2018

5:00 PM Eastern, May 15, 2019

The estimated time to complete this activity is 1 hour. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 1.0 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE068 - The 340B Pharmacy Program and the HTC

The Veterans Health Care Act of 1992 designated federally-recognized and -funded Hemophilia Diagnostic and Treatment Centers (HTCs) as covered entities eligible to participate in the 340B Drug Pricing Program. HTCs were henceforth able to utilize the 340B Program to stretch federal grant funding and develop capacity to provide robust, comprehensive services to all patients served. In 2015 federal grants divided among 140+ HTCs in the U.S. totaled only $4.9 million from Health Resources and Services Administration (HRSA) (to be used for services not covered by insurance) and an additional $5 million from the Centers for Disease Control and Prevention (CDC) (earmarked for surveillance and research).1 Thus, in this era of fiscal constraint brought on by budget cuts and the effects of federal sequestration, HTC participation in the 340B Pharmacy Program has provided a critical means of financial support for HTC services enabling provision of comprehensive care for all patients seen at HTCs with these programs. Approximately 100 of the 140 HTCs participate in the 340B Pharmacy Program.2 As a condition of participation, these centers must invest all revenues from the program back into patient services, care coordination, research and other programs that directly benefit patients. The purpose of this module is to examine the 340B Pharmacy Program, its role in homecare of hemophilia, eligibility and enrollment, restrictions and requirements, and special considerations for operation of such a program.

• Explain homecare provision and the role of the 340B Pharmacy Program
• Introduce Section 340B of the Veterans Health Care Act
• Define 340B Pharmacy Program eligibility and enrollment
• Identify restrictions and requirements to operate a 340B Pharmacy Program
• Discuss special considerations of operating a 340B Pharmacy Program at a federally-recognized U.S. Hemophilia Treatment Center (HTC)

Nurses, pharmacists, pharmacy technicians, and multidisciplinary providers in the U.S. Hemophilia Treatment Center (HTC) Network who wish to learn more about establishing and/or managing a 340B Pharmacy Program and the role of these programs in the U.S. HTC Network

This module will provide a brief history of the 340B Pharmacy Program established in 1992 under the Veterans Healthcare Act and the role of these programs in lowering costs of care and providing revenue for the HTC which must be reinvested into programs and services provided directly to HTC patients. For those HTCs in consideration of starting a 340B Pharmacy Program, this module also introduces the Office of Pharmacy Affairs requirements and regulations for such a program, including definitions of key terms and information about the application process, program maintenance, and potential program audits. Finally, this module will recommend the Hemophilia Alliance as a resource for HTCs with 340B Pharmacy Programs as well as those who are interested in learning more about the operation and management of such programs at HTCs.

• Jeff Blake, MBA, CEBS
• Madhu Koneru, PharmD

May 22, 2018

5:00 PM Eastern, May 22, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE108 - Adherence to Prophylaxis in Hemophilia

Nonadherence to treatment regimen is a prevalent problem of patients with chronic disorders. It is estimated that approximately half of the patients with a chronic disease have problems following their prescribed regimen to the extent that they are unable to obtain optimal clinical benefit. This learning activity explores issues relating to treatment adherence in hemophilia. Topics include the current guidelines regarding prophylactic treatment of hemophilia, a quantification and definition of treatment adherence, an exploration of studies measuring adherence in hemophilia, quantitative measures of adherence, barriers to treatment adherence, methods to increase adherence, and issues of adherence with extended half-life products.

• Discuss current guidelines regarding prophylactic treatment of hemophilia
• Quantify prophylactic prescription rates in the U.S. and internationally
• Define treatment adherence
• Explore studies measuring adherence to prophylactic factor replacement in hemophilia
• Interpret quantitative measures of adherence including VERITAS-Pro
• Identify three barriers to prophylactic treatment of hemophilia
• Describe patient-oriented and provider initiated methods to increase patient adherence
• Explore issues of adherence to regimens utilizing extended half-life products

Health care professionals, including nurses, nurse practitioners, physical therapists, and social workers practicing at federally-funded hemophilia treatment centers (HTCs) and treating patients who utilize prophylactic factor replacement to treat hemophilia.

This module will review current guidelines regarding prophylactic treatment of hemophilia. It will take a close look at the different definitions of adherence and use the VERITAS-Pro to interpret quantitative measures. Finally, the module will show different methods to increase patient adherence.

• Natalie Duncan, MPH
• Katie Khair, PhD
• Courtney Thornburg, MD, MS

November 20, 2017

5:00 PM Eastern, November 20, 2018

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Partners in Bleeding Disorders Education.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE107 - Improving Access to Care Through Outreach

The purpose of this activity is to explore the importance of access to care and evaluate common barriers to care faced by patients. We will introduce outreach as a model of care, including telemedicine, and review logistical and cost considerations associated with planning an outreach clinic. Two detailed case studies will enable the learner to apply information gained through this activity.

• List four potential barriers to care in vulnerable populations
• Define outreach as it relates to health care delivery
• Differentiate three telemedicine delivery methods
• Discuss considerations involved in planning and financing an outreach clinic
• Summarize the current consensus on the cost-effectiveness of outreach efforts
• Identify current barriers to care, appropriate interventions, and associated outcomes related to a review of detailed patient scenarios

This activity is intended for staff employed within the U.S Hemophilia Treatment Center Network, or USHTCN, to include nurses, social workers, physicians, physical therapists, administrators, and other professionals who wish to understand outreach as it relates to care in vulnerable populations. The activity may also be of interest to hospital or institutional staff responsible for planning and managing outreach programs.

This module describes how the approaches to using outreach clinics may help overcome challenges to the delivery of specialty medical care to individuals with bleeding disorders.
The presenters will review the barriers to patients (geographic, cultural, economic) as well as hemophilia treatment centers (administrative, cost, credentialing) that HTC staff must consider when initiating or maintaining an outreach program.

• Marcia L. Bird, LMSW, MSW
• Brenda Riske, RN, MSN, MBA, MPA
• Brian M. Wicklund, MDCM, MPH

February 20, 2018

5:00 PM Eastern February 28, 2019

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 80% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 1.0 contact hour under ANCC criteria.

This program is Approved by the National Association of Social Workers (Approval #886604222-2203) for 1 continuing education contact hours.

The Indiana Hemophilia and Thrombosis Center/Partners PRN is an approved provider of continuing social work education by the National Association of Social Workers (Provider #886604222).

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

Hemophilia 101 for Nonclinical Staff at HTCs (non CE)

This module is designed to provide information about the U.S. federally funded hemophilia treatment center (or HTC) network (referred to as USHTCN) and the multidisciplinary comprehensive care provided at HTCs. The module also reviews the key concepts of data collection and research at HTCs. Providing an overview of the scientific precepts of hemophilia, the module further explains how data and clinical care are integrated and pertinent to the important role of nonclinical staff at HTCs.

• Identify different parts of the federally funded U.S. HTC network
• Examine key components of the hemophilia comprehensive care model
• Review data collection requirements for linking the comprehensive care model to health outcomes
• Explain general scientific precepts of bleeding disorders
• Evaluate how data and clinical care are integrated and pertinent to the role of nonclinical staff

This module is designed for nonclinical professionals in the HTC network, including data collection personnel, administrators, HTC staff interacting with 340B programs.

This module is divided into three sections:
Section I covers the U.S. Hemophilia Treatment Center Network (USHTCN) and the multidisciplinary comprehensive care model practiced at HTCs,
Section II reviews the data collection and research at HTCs, and
Section III discusses the clinical and medical issues in hemophilia at a 101 level and the importance of these issues to nonclinical staff.

• Brenda Riske, MS, MBA, MPA
• Regina Butler, RN
• Jim Munn, RN, MS

January 30, 2015

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE046 - HTC Multidisciplinary Team: Roles and Responsibilities

This online learning activity aims to enable learners from the federally-recognized U.S. Hemophilia Treatment Center Network (USHTCN) to develop competencies regarding the roles and responsibilities of members of the core team and extended multidisciplinary team for hemophilia comprehensive care, as outlined in recommendations by the Medical and Scientific Advisory Council (MASAC) and guidelines from the National Hemophilia Foundation and McMaster University.

• Identify roles and responsibilities of members of the HTC multidisciplinary hemophilia comprehensive care team as designated in formal guidance from the National Hemophilia Foundation (NHF) and McMaster University.

Clinical staff employed within the U.S. federally recognized hemophilia treatment center (HTC) network who wish to learn more about the roles and responsibilities of members of the multidisciplinary hemophilia comprehensive care team
Non-clinical HTC staff who wish to enhance their knowledge of the HTC multidisciplinary team

This Module will introduce MASAC Document #132, provide an overview of the roles of core members of the comprehensive care team, and introduce extended multidisciplinary team members.

• Susan Cutter, MSW, LCSW, MPA
• Karen Droze, MS
• Ann Forsberg, MA, MPH
• Nicole Hroma, PT
• Susan Zappa, RN-BC, CPN
• Natalie Duncan, MPH

April 3, 2018

5:00 PM Eastern, April 3, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE045 - U.S. Hemophilia Treatment Center Network: The Big Picture

The purpose of this online educational module is to familiarize staff of the 140+ federally recognized U.S. hemophilia treatment centers (HTCs) with the network to which those HTCs belong. The organization of the network has allowed the development and refinement of the hemophilia comprehensive care model, associated with significant reduction in hemophilia morbidity and mortality. Funding sources, data collection efforts, and research findings are described.

• Describe the organization of the U.S. hemophilia treatment center (HTC) network
• Examine the key components of the hemophilia comprehensive care model
• Evaluate significant sources of funding for the U.S. HTC network
• Explain the importance of HTC data collection
• Identify three ongoing data collection systems
• List three important research findings regarding the U.S. HTC network

Nurses, physicians, physical therapists, social workers and other clinical staff within the U.S. HTC network who wish to learn more about the organization, services provided, funding, and outcomes of the network. Additional HTC staff who wish to enhance their knowledge of the U.S. HTC network

This module will describe the establishment of specialized care for hemophilia by Biggs, McFarlane, and Kasper and illustrate the placement of HTCs and regions on a U.S. map. It will also show HTC population by diagnosis since 1990 and provide the MASAC Standards and Criteria for care at HTCs. This module will describe characteristics of HTCs and provide a timeline of the U.S. HTC Network. This module will then list nine components of the comprehensive care model, identify comprehensive care team members, define and discuss family-centered care, discuss comprehensive care outreach, identify goals of comprehensive care clinic, and discuss HTC interactions with the patient. This module will also identify HTC funding sources, explain the Veteran’s Health Care Act 340B Factor Programs, graph the federal funding structure, discuss the role of partnerships with consumers, not in funding, but in supporting the network, discuss the core outcome measures of the Maternal and Child Health Bureau, and introduce ATHN and its activities. It will describe the purpose of the CDC Hemophilia Surveillance grant to support public health surveillance, prevention of complications of blood disorders, and blood safety, introduce the primary repositories for HTC data collection, and define the purpose of HTC data collection. This module will introduce Community Counts Surveillance Project, ATHNdataset (Clinical Manager), and Hemophilia & Thrombosis Data Set (HTDS). It will expand on discussion of HTDS, define current U.S. HTC Network research and data priorities, and explain the CHOICE Project. Finally, the module will review the outcomes of HTC care from the 6-state surveillance study, define health outcomes measurement and its purpose, and recall Universal Data Collection (UDC) System study purpose, enrollment, and findings.

• Susan Cutter, MSW, LCSW, MPA
• Karen Droze, MS
• Ann Forsberg, MA, MPH
• Nicole Hroma, PT
• Susan Zappa, RN-BC, CPN
• Natalie Duncan, MPH

March 5, 2018

5:00 PM Eastern, March 5, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE070 - Nutritional Considerations in Common Comorbidities of Hemophilia

This online learning activity aims to enable learners from the federally-recognized U.S. Hemophilia Treatment Center Network (USHTCN) to develop competencies regarding the roles and responsibilities of the registered dietitian nutritionist on the multidisciplinary comprehensive care team, and to gain familiarity with nutritional considerations in common comorbidities of hemophilia, to include hepatitis C, HIV, iron deficiency anemia, osteoporosis, obesity, and dyslipidemia.

• Discuss the roles and responsibilities of the Registered Dietitian Nutritionist on the hemophilia comprehensive care team
• Examine the components of the nutrition assessment administered by the HTC Registered Dietitian Nutritionist
• Evaluate nutrition objectives and dietary interventions for common comorbidities of hemophilia
• Identify important considerations and discussion points for persons with hemophilia regarding dietary supplements

Registered dietitian nutritionists, nurses, physical therapists, social workers, and other members of the multidisciplinary comprehensive care team at U.S. Hemophilia Treatment Centers (HTCs) who are involved in or support the nutritional health of patients

At HTCs, patients may experience nutritional challenges related to hepatitis C, HIV, iron deficiency anemia, osteoporosis, overweight and obesity, and dyslipidemia. There is an important role for a registered dietitian or someone serving in this capacity to promote optimal nutritional health, provide nutrition services to both pediatric and adult patients by making appropriate nutrition recommendations depending on an individual's needs, and provide ongoing support until an individuals' nutrition goals are met. This module seeks to address this need.

• Tina Willis, MA, RDN

May 3, 2018

5:00 PM Eastern, May 3, 2019

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE082 - Dear Diary: The Importance of Infusion Logs in Hemophilia Home Treatment

This online learning activity aims to enable the learner to increase knowledge pertaining to the role and importance of infusion log-keeping for hemophilia home treatment; as well as to familiarize the learner with patient/provider viewpoints and clinical application of infusion logs in hemophilia care.

• Explain the importance of maintaining an accurate patient medical record
• Outline the initial concerns about home treatment of hemophilian
• Compare the qualities of paper and electronic infusion logs
• Identify at least three potential applications of infusion logs in clinical practice

Nurses and other multidisciplinary hemophilia treatment center (HTC) staff engaged in the care of patients who utilize home infusion therapy for treatment of hemophilia.

While most hemophilia treatment centers throughout the United States encourage or require patients to maintain home infusion logs, there is a notable absence of literature regarding how these logs are used in clinical practice. There is also a shortage of concise information summarizing the purpose of infusion logs, types of infusion logs, patient and provider sentiments regarding logs, and uses for logs. This module aims to fill that gap by providing nurses with a very straightforward overview of these important items, with the hope that it will ultimately encourage greater clinical applications of infusion logs.

• Natalie Duncan, MPH

August 16, 2018

5:00 PM, Eastern, August 16, 2019/p>

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

TThis activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE106 - Clinical Management of Inhibitors Module 2: Treatment of Bleeding Episodes.

The purpose of this activity is to enable the learner to deepen their knowledge concerning treatment of bleeding episodes in persons with hemophilia and inhibitors, the use of prophylactic treatment in these individuals, and surgical management of these individuals, with the goal of improving care quality, consistency, and outcomes for persons with hemophilia and inhibitors.

• Describe considerations that influence treatment options
• Evaluate the treatment options for management of acute bleeds in individuals with inhibitors
• Describe the potential use of prophylactic therapy in individuals with congenital hemophilia and inhibitors
• Review the use of bypassing agents in the surgical setting for inhibitor patients
• Identify psychosocial issues related to inhibitors

This module is intended for nursing professionals and other health care providers at hemophilia treatment centers (HTCs) who are involved in the management of individuals with congenital hemophilia who have inhibitors. The module is also intended for health care professionals involved in the management of individuals with acquired inhibitors directed at factor VIII (acquired hemophilia).

Inhibitor development is one of the most serious and costly complications of hemophilia. Standard factor replacement therapy is often no longer possible, which complicates the treatment of bleeds and results in significant morbidity. A recent review by investigators from the US Centers for Disease Control and Prevention (CDC) and the Hemophilia Treatment Center Network (HTCN) found that males with severe hemophilia A and a current inhibitor are at increased risk of death. Definitive guidelines for the clinical management of inhibitors are sparse, as are guidelines for immune tolerance induction to eradicate the inhibitors. Nurses need more education on the risk factors, clinical presentation and impact of inhibitors. In particular, nurses need practical education on clinical management of patients with inhibitors to factor VIII or factor IX. In addition, nurses at hemophilia treatment centers also are responsible for treating individuals with acquired hemophilia, a very rare but potentially life-threatening condition. The risk factors, clinical manifestations and treatment of acquired hemophilia are distinct from those of inhibitors in congenital hemophilia, but education on acquired hemophilia is limited.
This series of modules seeks to address these educational gaps. Module 1 covers the risk factors for and classification of inhibitors and includes case scenarios to describe how FVII, FIX, and acquired FVIII inhibitors may present in the clinical setting; Module 2 reviews the strategies to treat bleeding episodes in patients with inhibitors; Module 3 focuses on the immune tolerance induction regimens that may be used to eradicate inhibitors.

• Jennifer Maahs, RN-BC, MSN, PNP
• Reviewer: Jayson Stoffman, MD, FRCP(C)

November 28, 2017

5:00 PM Eastern, November 27, 2018

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Partners in Bleeding Disorders Education.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.